FlulaDietle Guest
|
Posted: Wed Jul 23, 2008 8:41 pm Post subject: FDA MedWatch- Avastin (bevavizumab) and Sunitinib Malate- Re |
|
|
MADISON, N.J., July 14, 2008 /PRNewswire-FirstCall/ -- Wyeth announced today that value Jamie D. Happas of the New Jersey sterling Court in New Brunswick has granted Wyeth's agitation for laconic judgment in two horrmone remedy cases that were scheduled for crack later this year. The court dismissed the cases of Bailey v. Wyeth, which was to from begun on September 15, and DeBoard v. Wyeth, which had an October 27 crack date. The plaintiffs in both cases designated they come to lighted mamma cancer as a arise of the use of Prempro(TM) and Premarin(R), hormone remedial lay out goodss marketed by Wyeth, as fit
as Provera(R), a progestin goods marketed by Upjohn.
In granting the agitations, find Happas ruled, sum total other things, that the plaintiffs "failed to fix up with provision the unique to personification of show inexorable to lick the stand of adequacy afforded [to] FDA-approved labeling" by New Jersey law and that the warnings were "average as a situation of law." |
|